Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation. 1987

J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft

Cimetidine 1000 mg/day and phenobarbital 100 mg/day were given to five healthy volunteers for 13 days in order to investigate the combined effect and time course of inhibition and induction on hepatic drug metabolism. The one-sample antipyrine saliva clearance (APC) and urinary metabolite profile were measured weekly, once before, two times during and four times after drug administration. On the second day of drug treatment APC was 0.7 fold and the formation clearance of the 3 oxidized metabolites 0.6 fold decreased owing to an early inhibition by cimetidine (p less than 0.05). After 8 days of concomitant drug administration, i.e. when the drug mediated inhibition and induction are supposed to be at maximum, mean APC was 0.85 times the initial value (p greater than 0.05), whereas the formation clearances of nor- and 3-hydroxymethylantipyrine were still significantly depressed. Four and 11 days after drug withdrawal, when phenobarbital, but not cimetidine could be demonstrated in plasma, APC was 1.2 times the initial value (p less than 0.05). The results suggest, that the respective effects of cimetidine and phenobarbital on antipyrine elimination are additive, when given concomitantly, but that cimetidine exerts a relatively greater inhibition in the phenobarbital induced state.

UI MeSH Term Description Entries
D008297 Male Males
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
August 1983, Xenobiotica; the fate of foreign compounds in biological systems,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
October 2005, Archives of pharmacal research,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
March 1982, Gastroenterology,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
July 1981, Gastroenterology,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
December 1986, Xenobiotica; the fate of foreign compounds in biological systems,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
January 1986, Drug metabolism and disposition: the biological fate of chemicals,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
January 1987, Clinical therapeutics,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
November 1989, The Journal of pharmacology and experimental therapeutics,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
January 1983, Drug metabolism and disposition: the biological fate of chemicals,
J Sonne, and M Døssing, and H E Poulsen, and H Pilsgaard, and B Rasmussen, and S Loft
April 1991, Biochemical pharmacology,
Copied contents to your clipboard!